Preclinical validation of Oncodesign’s first radiotracer prior to human application 17/12/15 DOWNLOAD
Oncodesign presents novel LRRK2 inhibitor jointly discovered with Ipsen at the 2015 Neurosciences meeting in Chicago 21/10/15 DOWNLOAD